ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

New Publications

January 20, 1989

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

DCT Board Okays Concepts For New Radiation Studies

June 12, 1987

Kidney, Bladder Cancer Causes, Treatment, Need More Research, NCI Advisors Find

July 26, 2002

R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”

November 13, 1987

Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer

July 31, 2009